Yonsei Med J.  2009 Oct;50(5):677-682. 10.3349/ymj.2009.50.5.677.

A Study of Oxidative Stress Parameters in Anti-Helicobacter Pylorus Immunoglobulin G Positive and Negative Gastric Cancer Patients

• Noyan T
• Guducuoglu H
• Ilhan M

• KMID: 1103822
• DOI: http://doi.org/10.3349/ymj.2009.50.5.677

Abstract

PURPOSE
Helicobacter pylorus (HP) is a Gram-negative spiral-shaped microaerophilic bacterium, which colonizes in the gastric mucosa of humans. The gastric human pathogen HP causes chronic gastritis and ulcers, and has a strong relationship with gastric cancer. The aim of this study was to determine advanced oxidation protein products (AOPP) levels, activities of myeloperoxidase (MPO) and catalase (CAT) in two groups. MATERIALS AND METHODS: For this aim, one group included 30 patients with gastric cancer (Group 1) and the other included 30 subjects with non-gastric cancer and Anti-HP immunoglobulin (Ig) G antibody positive (group 2). Anti-HP IgG antibody test values were found as positive in fifty percent of group 1 and all of the group 2 patients. RESULTS: Significantly increased AOOP levels were found in group 1 (p < 0.05) compared to group 2. There were no significant differences between the groups in regard to activities of MPO and CAT. In addition, AOPP level, MPO and CAT activities were similar among the Anti-HP IgG positive and negative subgroups of group 1 patients. CONCLUSION: The result of this study indicated that gastric cancer patients were characterized by increased protein oxidation, whereas there was no significant difference in oxidative stress parameters and antioxidant enzyme activity between the Anti-HP IgG positive and negative gastric cancer patients.

Keyword

Gastric cancer; helicobacter pylorus; oxidative stress

MeSH Terms

Adult
Aged
Catalase/blood
Female
Helicobacter Infections/*immunology/metabolism
Helicobacter pylori/*immunology
Humans
Immunoglobulin G/*blood
Male
Middle Aged
Oxidation-Reduction
*Oxidative Stress
Peroxidase/blood
Stomach Neoplasms/blood/immunology/*metabolism

Reference

1. Godlewska R, Dzwonek A, Mikuła M, Ostrowski J, Pawłowski M, Bujnicki JM, et al. Helicobacter pylori protein oxidation influences the colonization process. Int J Med Microbiol. 2006. 296:321–324.

2. Akcam M, Elmas O, Yilmaz A, Cağlar S, Artan R, Gelen T, et al. Myeloperoxidase, xanthine oxidase and superoxide dismutase in the gastric mucosa of Helicobacter pylori positive and negative pediatric patients. Mol Cell Biochem. 2006. 290:125–130.

3. Nardone G, Morgner A. Helicobacter pylori and gastric malignancies. Helicobacter. 2003. 8:Suppl 1. 44–52.

4. Isakov V, Malfertheiner P. Helicobacter pylori and nonmalignant diseases. Helicobacter. 2003. 8:Suppl 1. 36–43.

5. Tummala S, Keates S, Kelly CP. Update on the immunologic basis of Helicobacter pylori gastritis. Curr Opin Gastroenterol. 2004. 20:592–597.

6. Elfvin A, Bölin I, Lönroth F, Fändriks L. Gastric expression of inducible nitric oxide synthase and myeloperoxidase in relation to nitrotyrosine in Helicobacter pylori-infected Mongolian gerbils. Scand J Gastroenterol. 2006. 41:1013–1018.

7. Farkas R, Selmeci L, Tulassay Z, Pronai L. Superoxide-dismutase activity of the gastric mucosa in patients with Helicobacter pylori infection. Anticancer Res. 2003. 23:4309–4312.

8. Felley CP, Pignatelli B, Van Melle GD, Crabtree JE, Stolte M, Diezi J, et al. Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter. 2002. 7:342–348.

9. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990. 87:1620–1624.

10. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett. 1997. 411:157–160.

11. Kimura A, Tsuji S, Tsujii M, Sawaoka H, Iijima H, Kawai N, et al. Expression of cyclooxygenase-2 and nitrotyrosine in human gastric mucosa before and after Helicobacter pylori eradication. Prostaglandins Leukot Essent Fatty Acids. 2000. 63:315–322.

12. Sakaguchi AA, Miura S, Takeuchi T, Hokari R, Mizumori M, Yoshida H, et al. Increased expression of inducible nitric oxide synthase and peroxynitrite in Helicobacter pylori gastric ulcer. Free Radic Biol Med. 1999. 27:781–789.

13. Kalousová M, Zima T, Tesar V, Dusilová-Sulková S, Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res. 2005. 579:37–46.

14. Witko-Sarsat V, Gausson V, Nguyen AT, Touam M, Drüeke T, Santangelo F, et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int. 2003. 64:82–91.

15. Pullar JM, Vissers MC, Winterbourn CC. Living with a killer: the effects of hypochlorous acid on mammalian cells. IUBMB Life. 2000. 50:259–266.

16. Matteucci E, Biasci E, Giampietro O. Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics. Acta Diabetol. 2001. 38:187–189.

17. Winterbourn CC. Superoxide as an intracellular radical sink. Free Radic Biol Med. 1993. 14:85–90.

18. Witko-Sarsat V, Friedlander M, Capeillére-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996. 49:1304–1313.

19. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982. 78:206–209.

20. Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991. 196:143–151.

21. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006. 98:1445–1452.

22. Bagchi D, Bhattacharya G, Stohs SJ. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res. 1996. 24:439–450.

23. Ramarao N, Gray-Owen SD, Meyer TF. Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Mol Microbiol. 2000. 38:103–113.

24. Baik SC, Youn HS, Chung MH, Lee WK, Cho MJ, Ko GH, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res. 1996. 56:1279–1282.

25. Wang G, Conover RC, Benoit S, Olczak AA, Olson JW, Johnson MK, et al. Role of a bacterial organic hydroperoxide detoxification system in preventing catalase inactivation. J Biol Chem. 2004. 279:51908–51914.

26. Jacob RF, Mason RP. Lipid peroxidation induces cholesterol domain formation in model membranes. J Biol Chem. 2005. 280:39380–39387.

27. Scherer C, Müller KD, Rath PM, Ansorg RA. Influence of culture conditions on the fatty acid profiles of laboratory-adapted and freshly isolated strains of Helicobacter pylori. J Clin Microbiol. 2003. 41:1114–1117.

28. Sun CQ, O'Connor CJ, Roberton AM. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol. 2003. 36:9–17.

29. Wang G, Hong Y, Johnson MK, Maier RJ. Lipid peroxidation as a source of oxidative damage in Helicobacter pylori: protective roles of peroxiredoxins. Biochim Biophys Acta. 2006. 1760:1596–1603.

30. Wang G, Olczak AA, Walton JP, Maier RJ. Contribution of the Helicobacter pylori thiol peroxidase bacterioferritin comigratory protein to oxidative stress resistance and host colonization. Infect Immun. 2005. 73:378–384.

31. Wang G, Alamuri P, Maier RJ. The diverse antioxidant systems of Helicobacter pylori. Mol Microbiol. 2006. 61:847–860.

32. Bancel B, Esteve J, Souquet JC, Toyokuni S, Ohshima H, Pignatelli B. Differences in oxidative stress dependence between gastric adenocarcinoma subtypes. World J Gastroenterol. 2006. 12:1005–1012.

33. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995. 55:562–565.

34. Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter. 1999. 4:135–139.

35. Vijayan G, Sundaram RC, Bobby Z, Hamide A, Selvaraj N, Dasse NR. Increased plasma malondialdehyde and fructosamine in anemic H pylori infected patients: effect of treatment. World J Gastroenterol. 2007. 13:796–800.

36. Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin Chim Acta. 2006. 366:190–195.

37. Davies KJ. Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem. 1987. 262:9895–9901.

38. Park S, Kim WS, Choi UJ, Han SU, Kim YS, Kim YB, et al. Amelioration of oxidative stress with ensuing inflammation contributes to chemoprevention of H. Pylori-associated gastric carcinogenesis. Antioxid Redox Signal. 2004. 6:549–560.

39. Takemura T, Granger DN, Evans DJ Jr, Evans DG, Graham DY, Anderson DC, et al. Extract of Helicobacter pylori induces neutrophils to injure endothelial cells and contains antielastase activity. Gastroenterology. 1996. 110:21–29.

40. Mori M, Suziki H, Suzuki M, Kai A, Miura S, Ishii H. Catalase and superoxide dimutase secreted from Helicobacter pylori. Helicobacter. 1997. 2:100–105.

41. Durak I, Ormeci N, Akyol O, Canbolat O, Kavutçu M, Bulbül M. Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis. Dig Dis Sci. 1994. 39:721–728.

42. Bulbuloglu E, Inanc F, Bakaris S, Kantarceken B, Cetinkaya A, Cağlar R, et al. Association of adenosine deaminase, superoxide dismutase, and catalase activities with Helicobacter pylori. Dig Dis Sci. 2005. 50:2296–2299.

43. Al-Shukaili A, Al-Jabri AA, Al-Moundhri MS. Prognostic value of auto-antibodies in the serum of Omani patients with gastric cancer. Saudi Med J. 2006. 27:1873–1877.

44. Dursun H, Bilici M, Uyanik A, Okcu N, Akyüz M. Antioxidant enzyme activities and lipid peroxidation levels in erythrocytes of patients with oesophageal and gastric cancer. J Int Med Res. 2006. 34:193–199.

45. Starzyñska T, Malfertheiner P. Helicobacter and digestive malignancies. Helicobacter. 2006. 11:32–35.

46. Dincer Y, Himmetoglu S, Akcay T, Ersoy EY, Gunes KN, Tortum O. Prognostic significances of oxidative DNA damage evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzymes in patients undergoing resection of gastric and colon carcinoma. Neoplasma. 2007. 54:131–136.

47. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006. 160:1–40.